Chief Commercial Officer · KalVista Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$51K
Shares
3,813
Price
$13.45
Executed
Nov 24, 2025
Disclosed
Dec 4, 2025
Disclosure timeline10 days from execution to publication · legal deadline 2 business days
Nov 24 executedDec 4, 2025 disclosed
KALV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 8 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Sweeny Nicole filed this Form 4 reporting a open-market sale of KALV on Nov 24, 2025. It became public on Dec 4, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Sweeny Nicolecik:0001827505
Issuer
KalVista Pharmaceuticals, Inc.cik:0001348911
Revision history · 0
No field has changed since this record was first ingested.
